The FDA has approved Medtronic’s Enlite sensor with iPro2 Professional Continuous Glucose Monitoring (CGM) system. The sensor is a disposable glucose sensor. It provides the user with more comfort and can be worn for up to 6 days. It is 69% smaller than the previous Medtronic sensor.

“We fundamentally believe that to improve outcomes for people with diabetes, physicians need advanced insights to optimize therapy and people with diabetes need to understand the context behind glucose fluctuations to drive behavior change,” said Laura Stoltenberg, vice president and general manager, Non-Intensive Diabetes Therapies at Medtronic.